Form 4 for GH Guardant Health, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001562135-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-15 | GH | EAGLE CRAIG | Chief Medical Off | M - OptEx | $0.00 | +15.1K | 74.0K | +26% | $0 |
| D | 2026-03-17 | 2026-03-15 | GH | EAGLE CRAIG | Chief Medical Off | F - Tax | $85.49 | -7,661 | 66.4K | -10% | -$654.9K |
| DM | 2026-03-17 | 2026-03-15 | GH | EAGLE CRAIG | Chief Medical Off | M - OptEx | $0.00 | -15.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | M | A | 13,712 | $0.00 | 72,639 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-15 | M | A | 1,402 | $0.00 | 74,041 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-15 | F | D | 7,661 | $85.49 | 66,380 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 4 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 1,402 | $0.00 | 1,402 | D | $0.00 · — to — | 1,402 Common Stock | (F4) This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. (F3) Not applicable for Restricted Stock Units. |
| 5 | Derivative | Performance-Based Restricted Stock Units | 2026-03-15 | M | D | 13,712 | $0.00 | 0 | D | $0.00 · — to — | 13,712 Common Stock | (F2) This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. (F3) Not applicable for Restricted Stock Units. |